Control Group for Parkinson's (NCT07322939)
Improve walking using visual feedback
- Trial ID
- NCT07322939
- Official Title
- Effects of Visual Indicator Exercises for the Trunk and Lower Extremities on Activity and Participation in Parkinson's Disease
- Goal
- Improve walking using visual feedback
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Hasan Kalyoncu University
- Study Type
- INTERVENTIONAL
- Enrollment
- 32 participants
- Conditions
- Parkinson Disease, Balance Impairment, Exercise Training, Postural Control
- Interventions
- Control Group, Visual Feedback Exercise Group
Summary For Families
Researchers want to know whether using visual indicators during trunk and lower limb exercises can improve balance, posture, mobility, and participation in daily life for people with Parkinson's. The program gives real-time visual cues so you can see and correct trunk alignment and weight shifts, with the aim of retraining balance reactions and making gait and functional movements steadier; it is a non-drug rehabilitation approach used alongside your oral antiparkinsonian meds, not a replacement. Outcomes with the visual feedback program are compared to a control group that does the same exercise program without the visual indicators. Adults 18 to 85 with idiopathic Parkinson's at Hoehn and Yahr stages 1 to 3 who are on oral antiparkinsonian treatment only can join, while people with major musculoskeletal, cardiovascular, vestibular, other neurological or psychiatric disorders, or poor vision are excluded.
Locations
- Hasan Kalyoncu University, Gaziantep, Şahinbey, Turkey (Türkiye)
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Control Group. Researchers want to know whether using visual indicators during trunk and lower limb exercises can improve balance, posture, mobility, and participation in daily life for people with Parkinson's. The program gives real-time visual cues so you can see and correct trunk alignment and weight shifts, with the aim of retraining balance reactions and making gait and functional movements steadier; it is a non-drug rehabilitation approach used alongside your oral antiparkinsonian meds, not a replacement. Outcomes with the visual feedback program are compared to a control group that does the same exercise program without the visual indicators. Adults 18 to 85 with idiopathic Parkinson's at Hoehn and Yahr stages 1 to 3 who are on oral antiparkinsonian treatment only can join, while people with major musculoskeletal, cardiovascular, vestibular, other neurological or psychiatric disorders, or poor vision are excluded.
- Who can participate?
- Participants must be between 18 Years and 85 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 4 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- There is no placebo group. Everyone receives an active treatment; the study compares one treatment against another.
- How many visits does this trial involve?
- You will attend supervised exercise sessions 3 days per week for 8 weeks.